OTCMKTS:ARSUF

Fagron (ARSUF) Stock Price, News & Analysis

Fagron logo
$26.95 0.00 (0.00%)
As of 11/19/2026 12:45 PM Eastern

About Fagron Stock (OTCMKTS:ARSUF)

Advanced

Key Stats

Today's Range
$26.95
▼
$26.95
50-Day Range
$25.80
▼
$27.50
52-Week Range
$25.80
▼
$27.90
Volume
1,260 shs
Average Volume
230 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fagron is a pharmaceutical company focused on pharmaceutical compounding—the preparation of customized medicines to meet the needs of individual patients. It supplies pharmacies, hospitals, clinics and other healthcare providers with ingredients, products and services used to prepare compounded medications.

The company’s offerings include active pharmaceutical ingredients and other compounding materials, finished formulations, equipment and packaging, as well as compounding services. These include sterile preparations and other customized medicines for healthcare settings.

Founded in 1990, Fagron serves customers across Europe, North America, Latin America and other international markets. Its business combines product supply with specialized expertise and services supporting the preparation of personalized medicines.

AI Generated. May Contain Errors.

Fagron Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

ARSUF MarketRank™: 
0.60325938099 of 5 stars

Fagron scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Fagron.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fagron is -18.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fagron is -18.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Fagron has a short interest ratio ("days to cover") of 880.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Fagron has recently decreased by 29.67%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Fagron pays a meaningful dividend of 1.72%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fagron does not have a long track record of dividend growth.

  • Read more about Fagron's dividend.
  • News Sentiment

    Fagron has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Fagron this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Fagron insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    53.76% of the stock of Fagron is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Fagron's insider trading history.
Receive ARSUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fagron and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARSUF Stock News Headlines

Fagron (OTCMKTS:ARSUF) Shares Up 2.4% - Here's What Happened
CFA: Bank of America Said THIS
On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.tc pixel
Fagron NV (ARSUF) Q3 2025 Sales Call Transcript
Fagron delivers topline growth of 21.5% to €173 million
See More Headlines

ARSUF Stock Analysis - Frequently Asked Questions

Fagron's stock was trading at $23.50 at the start of the year. Since then, ARSUF stock has increased by 14.7% and is now trading at $26.95.

Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ARSUF
CIK
N/A
Fax
N/A
Employees
3,282
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (OTCMKTS:ARSUF) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners